Post-exposure vaccination against Mycobacterium tuberculosis.
Enhancing immunity to tuberculosis in animal models after exposure to the infection has proved difficult. In this study we used a newly described flow cytometric technique to monitor changes in cell populations accumulating in the lungs of guinea pigs challenged by low-dose aerosol infection with Mycobacterium tuberculosis and vaccinated 10 days later. On day 40 after infection the fusion protein F36 and a pool of Ag85A and ESAT6 vaccines had significant effects on the bacterial load, showed increased expression of the activation marker CD45+ on CD4+ T cells, and reduced numbers of heterophils. Lung pathology and pathology scores were marginally improved in animals given these vaccines, but lymph node pathology was not influenced. Despite early effects no changes in long-term survival were seen. These results suggest that a single post-exposure vaccination can initially slow the disease process. However, this effect is transient, but this could be of use in an multidrug resistant/extremely drug resistant outbreak situation because it could potentially slow the infection long enough to complete drug susceptibility testing and initiate effective chemotherapy.
Henao-Tamayo
Marcela
M
Colorado State University, Fort Collins, CO 80523-1682, USA.
Palaniswamy
Gopinath S
GS
Smith
Erin E
EE
Shanley
Crystal A
CA
Wang
Baolin
B
Orme
Ian M
IM
Basaraba
Randall J
RJ
DuTeau
Nancy M
NM
Ordway
Diane
D
D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D004195:Disease Models, Animal; D018450:Disease Progression; D005260:Female; D005434:Flow Cytometry / Q000379:methods; D006168:Guinea Pigs; D017493:Leukocyte Common Antigens / Q000378:metabolism; D008168:Lung / Q000276:immunology / Q000382:microbiology; D009169:Mycobacterium tuberculosis / Q000276:immunology / Q000302:isolation & purification; D016176:T-Lymphocyte Subsets / Q000276:immunology; D032581:Tuberculosis Vaccines / Q000276:immunology*; D014397:Tuberculosis, Pulmonary / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D014400:Tuberculosis, Splenic / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control; D014611:Vaccination / Q000379:methods
D032581:Tuberculosis Vaccines; D017493:Leukocyte Common Antigens